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Abstract
AIM
To investigate the total blood loss (TBL) and the safety 
with respect to the re-amputation rate after transtibial 
amputation (TTA) conducted with and without a 
tourniquet. 
METHODS
The study was a single-centre retrospective cohort 
study of patients with a primary TTA admitted between 
January 2013 and April 2015. All patients with a primary 
TTA were assessed for inclusion if the amputation 
was performed because of arteriosclerosis or diabetic 
complications. All patients underwent a standardized 
TTA procedure that was performed approximately 10 
cm below the knee joint and performed with sagittal 
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flaps. The pneumatic tourniquet, when used, was 
inflated around the femur to a pressure of 100 mmHg 
above the systolic blood pressure. The number of blood 
transfusions within the first four postoperative days was 
recorded. The intraoperative blood loss (OBL), which is 
defined as the volume of blood lost during surgery, was 
determined from the suction volume and by the weight 
difference of the surgical dressings. The trigger for a 
blood transfusion was set at a decrease in the Hgb level 
< 9.67 g/dL (6 mmol/L). Transfusions were performed 
with pooled red blood cells containing 245 mL per 
portion, which equals 55 g/L of haemoglobin. The TBL 
during the first four postoperative days was calculated 
based on the haemoglobin level and the estimated 
blood volume. The re-amputation rate was evaluated 
within 30 d. 
RESULTS 
Seventy-four out of 86 consecutive patients who 
underwent TTA within the two-year study period were 
included in the analysis. Of these, 38 were operated 
on using a tourniquet and 36 were operated on with-
out using a tourniquet. There were no significant 
preoperative differences between the groups. The 
patients in both groups had a postoperative decrease 
in their Hgb level compared with preoperative baseline 
values. The patients operated on using a tourniquet 
received approximately three millilitres less blood 
transfusion per kilogram body weight compared with 
patients operated on without a tourniquet. The duration 
of surgery was shorter and the OBL was less for the 
tourniquet group than the non-tourniquet group, 
whereas no significant difference was observed for the 
TBL. The TBL median was 859 mL (IQR: 383-1315) in 
the non-tourniquet group vs  737 mL (IQR: 331-1218) 
in the tourniquet group (P  = 0.754). Within the 30-d 
follow-up period, 9 patients in the tourniquet group 
and 11 in the non-tourniquet group underwent a re-
amputation at the trans-femoral level. The use of a 
tourniquet showed no statistically significant association 
with the 30-d re-amputation at the femur level in the 
multiple logistic regression model (P  = 0.78). The only 
variable with a significant association with re-amputation 
was age (OR = 1.07; P  = 0.02).
CONCLUSION 
The results indicate that tourniquets do not cause 
severe vascular damage with an increased postoperative 
bleeding or failure rate as the result. 
Key words: Total blood loss; Intraoperative blood loss; 
Transtibial amputation; Lower extremity amputation; 
Pneumatic tourniquet; Re-amputation
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Core tip: The authors performed a retrospective cohort 
study on the use of tourniquets during transtibial 
amputation with the primary aim of comparing various 
estimates of blood loss and re-operation between 
the groups with or without a tourniquet. The basis 
for investigating this subject is the theoretical risk of 
increased bleeding due to vascular damage in the 
tourniquet group, which may, in turn, lead to increased 
risk of re-amputation due to local oedema, among other 
factors. We found no significant difference in the total 
blood loss when calculated on day four after surgery or 
in the 30-d re-amputation rate between the tourniquet 
and the non-tourniquet group.
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INTRODUCTION
Recent studies have illuminated the challenges in lower 
extremity amputation surgery where a high short-term 
amputation failure rate is especially notable[1,2]. No clear 
explanation for this result has yet been established. 
With this retrospective cohort study, we aimed to investi-
gate if the possible cause is related to the use of a 
pneumatic tourniquet during amputation. Studies have 
shown that the use of a tourniquet reduces the intra-
operative blood loss (OBL) and facilitates the procedure 
(decreases the duration of surgery) during transtibial 
amputations (TTA)[3]. However, despite this advantage, 
the use of tourniquets remains a controversial topic in 
amputation surgery due to potential complications[4,5]. 
There is a theoretical risk that the tourniquet could 
aggravate the blood loss during the first postoperative 
days. When the tourniquet pressure is applied to 
arteriosclerotic vessels, there is a risk of causing minor 
lesions and, as a result, seepage of blood. This seepage 
could be unrecognized by the operating surgeons due to 
the late onset re-perfusion of the limb after the release 
of the tourniquet[6] and cause severe postoperative 
bleeding. Such “hidden blood loss” could potentially lead 
to oedema of the stump and maybe associated with an 
increased risk of early re-amputation. 
The aims of this study were (1) to compare the total 
blood loss (TBL) evaluated on the fourth postoperative 
day in patients operated with or without the use of a 
tourniquet and (2) to evaluate if the use of tourniquet 
increases the risk of re-amputation within the first 30 
d after TTA performed with sagittal flaps (ad modum 
Persson). 
MATERIALS AND METHODS
The study was a single-centre retrospective cohort 
study of patients with a primary TTA admitted between 
January 2013 and April 2015. All patients with primary 
TTA were assessed for inclusion if amputated because 
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of arteriosclerosis or diabetic complications. Exclusion 
criteria were a bilateral amputation procedure, on-going 
gastrointestinal bleeding, amputation due to trauma or 
incomplete data or death before the final measurement 
of haemoglobin (Hgb). 
All patients underwent a standardized TTA pro-
cedure[7] performed approximately 10 cm below the knee 
joint and performed with sagittal flaps. The pneumatic 
tourniquet, when used, was inflated around the femur 
to a pressure of 100 mmHg greater than the systolic 
blood pressure[8]. It was released again at the end of the 
procedure but before final closure to secure haemostasis. 
The decision to use a tourniquet relied on the surgeons. 
Standardized care was provided for all patients regarding 
bandages, pain management, rehabilitation, fluid 
replacement, pausation of antiplatelet drugs, treatment 
with blood transfusions and thromboprophylaxis[9]. Tran-
examic acid was not administered. 
Blood loss 
The number of blood transfusions within the first four 
postoperative days was recorded where day 0 is the day 
of surgery (after the start of the surgical procedure). 
The OBL, which is defined as the volume of blood lost 
during surgery, was determined from the suction volume 
and by the weight difference of the surgical dressings. 
The trigger for a blood transfusion was set at a decrease 
in the Hgb level < 9.67 g/dL (6 mmol/L). Transfusions 
were performed with pooled red blood cells containing 
245 mL/portion, which equals 55 g/L of haemoglobin. 
The TBL during the first four postoperative days was 
calculated based on the haemoglobin level and the 
estimated blood volume. The blood volume and loss was 
determined according to gender, weight, height and the 
Hgb of the patient using formulae described in previous 
studies[10,11]:
Blood volume (l) = height (m)3 × 0.356 + weight 
(kg) × 0.033 + 0.183 for women, and Blood volume 
(l) = height (m)3 × 0.367 + weight (kg) × 0.032 + 
0.604 for men. Hgbloss = blood volume × (Hgbadm - 
Hgbfin ) + Hgbtrans, where Hgb loss is the calculated total 
haemoglobin loss (g), Hgbadm is the haemoglobin value 
on admission, Hgbfin is the final recorded haemoglobin 
value on day four and Hgbtrans is the total amount of 
haemoglobin (in grams) in the transfused red blood 
cells before the measurement of Hgbfin. The calculated 
blood loss was estimated using the following formula:
Blood loss in millilitre = (Hgbloss/Hgbadm) × 1000.
Other variables
Eight predictor variables (age, gender, body mass index, 
ASA score, duration of surgery, the rank of surgeon, 
intraoperative blood loss, and anti-fibrinolytic medication) 
were included in the TBL analysis due to their previously 
established influence on patient outcome[10,12]. Re-
amputations were included if performed within 30 d 
following the index amputation. Six patients died within 
the 30-d follow-up period, and of these six patients, 
all underwent re-amputation; these patients were still 
included in the re-amputation model.
Statistical analysis
Continuous data are presented as median values 
with interquartile ranges (IQRs) or mean values with 
standard deviations. Differences between the groups 
were tested using a t test or a Mann-Whitney U test 
based on the normal distribution assumption. Categorical 
data are presented as numbers and were compared 
using the χ2 test or Fisher’s exact test in cases with cell 
counts of five or less. The associations of TBL and OBL 
with tourniquets were analysed using univariable and 
multivariable linear regression. The models use either 
TBL or OBL as the dependent variable and all previously 
mentioned predictor variables along with tourniquets as 
independent variables. The residuals in the models were 
tested and found to be normally distributed. A logistic 
regression model with tourniquet as the dependent 
variable was performed to identify potential inherent 
selection bias. The association between the 30-d re-
amputation and the use of tourniquet was analysed 
using a multiple logistic regression model. The fit of 
the model was evaluated using a Hosmer-Lemeshow 
goodness of fit test. A P value of 0.05 was considered 
statistically significant. All analyses were performed by 
a biostatistician working in R 3.2.0 (R Foundation for 
Statistical Computing, Vienna, Austria). 
RESULTS
A total of 74 out of 86 consecutive patients who 
underwent TTA within the two-year study period were 
included in the analysis. Of these, 38 were operated 
on using tourniquets and 36 without. Six patients died 
before the 30-d follow-up (n = 3 in the tourniquet 
group and n = 3 in the non-tourniquet group). Trained 
residents or senior consultants performed the surgical 
procedures. Reasons for exclusion were bilateral 
amputation (n = 8), trauma (n = 2), and death before 
the fourth postoperative day (n = 2). There were 
no significant preoperative differences between the 
groups (Table 1). The patients in both groups had a 
postoperative decrease in their Hgb level compared with 
the preoperative baseline values, as illustrated in Figure 
1A. The patients operated on using tourniquets received 
approximately three millilitres less transfusion blood 
per kilogram body weight than the patients operated 
on without using a tourniquet (Figure 1B, P ≤ 0.03 
for all days). The duration of surgery was shorter, and 
the OBL was less for the tourniquet group compared 
with the non-tourniquet group, whereas no significant 
difference was observed for the TBL. When the median 
OBL was subtracted from the median TBL for all the 
patients in the two groups, no significant difference was 
found (Table 2, P = 0.241). Within the 30-d follow-up, 
9 patients in the tourniquet group and 11 in the non-
tourniquet group had a re-amputation at the trans-
femoral level.
The logistic regression analysis with tourniquet as 
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the dependent variable identified no potential selection 
bias. However, there was a tendency that patients with 
a greater body mass index more often had a tourniquet 
installed during surgery (P = 0.059). The univariable 
linear regression analysis revealed no significant effect 
on the TBL from any of the selected variables. Still, 
the average TBL was lower for women and when 
consultants performed the procedures (Table 3). The 
multiple linear regression model of factors influencing 
the OBL showed that the non-tourniquet group, on 
average, experienced a greater OBL (mean of 243 mL, 
P = 0.004) compared with the tourniquet group. No 
other variables showed a significant association with 
OBL. There was no significant difference between the 
two groups regarding the TBL (Table 3). The use of a 
tourniquet showed no statistically significant association 
with a 30-d re-amputation at the femur level in the 
multiple logistic regression model (P = 0.78). The 
only variable with a significant association with re-
amputation was age (OR = 1.07; P = 0.02). The 
Hosmer-Lemeshow goodness of fit test had a P-value of 
0.06 in the re-amputation model. 
DISCUSSION
We found that the use of a pneumatic tourniquet in 
  Variables All patients n  = 74 Tourniquet group n  = 38 Non-tourniquet n  = 36 P value
  Sex (female/male) 25/49 11/27 14/22 0.511
  Age (yr) 72.3 ± 11.0 71.3 ± 9.8 73.4 ± 12.1 0.415
  Height (cm) 172 ± 9 173 ± 9 171 ± 9 0.178
  Weight (kg) 74.2 ± 18.8 78.2 ± 18.6 70.1 ± 18.4 0.065
  Body mass index 25.0 ± 5.4 25.9 ± 5.5 23.9 ± 5.2 0.112
  Cause of amputation (diabetes/arteriosclerosis) 39/35 19/19 20/16 0.806
  ASA group 1-2/3-4 13/60 5/32 8/28 0.374
  Rank of surgeon, (resident/consultant) 49/25 24/14 25/11 0.745
  Preoperative hemoglobin (g/dL) 10.9 ± 1.6 11.2 ± 1.6 10.8 ± 1.4 0.246
  Preoperative 
  Thrombocyte (× 109/L) 
368 ± 150 352 ± 121 380 ± 169 0.481
  NSAID or acetylsalicylic acid (yes/no) 40/34 20/18 20/16 0.985
  Clopidogrel (yes/no) 14/60 8/30 6/30 0.854
Table 1  Demographic of the included patients
Data are presented as numbers or mean values with standard deviations. ASA: American Society of anesthesiologists; NSAID: Nonsteroidal anti-
inflammatory drug.
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Figure 1  The patients in both groups had a postoperative decrease in their Hgb level compared with the preoperative baseline values. A: Development in 
Haemoglobin, Day 0 = day of surgery; B: Transfusion requirements. 
A B
  All patients    n  = 711 Tourniquet n  = 35 Non-tourniquet n  = 36 P value
  Duration of surgery (min)   82 (66-106) 78 (60-97) 88 (72-112)    0.041
  Duration of Tourniquet (min) 30 (18-42)
  Intraoperative blood loss (mL)   250 (150-500)   200 (100-300) 300 (225-600) < 0.001
  Total blood loss from day 0-4 (mL)     773 (336-1218)     737 (331-1218)   859 (383-1315)    0.754
  Delta TBL-OBL (mL) 479 (66-855)   495 (115-900)   296 (-30-803)    0.241
Table 2  Perioperative data from included patients
Data are presented as median values with interquartile range. 1Three patients missing due to no registration of the intraoperative blood loss. TBL: Total 
blood loss; OBL: Intraoperative blood loss.
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dysvascular TTA surgery ad modum Persson does reduce 
the duration of surgery, the blood transfusion rate 
(millilitres of blood transfusion per kilogram bodyweight) 
and the OBL, but there was no significant difference in 
the TBL when evaluated on the fourth postoperative 
day. We found no evidence that the tourniquet causes 
severe damage to vessels and, therefore, an increased 
postoperative blood loss. However, although not 
significant, we did find that patients who were operated 
by a consultant experienced a lower blood loss than 
those operated by surgeons with less experience. We 
found no difference between the groups regarding 
re-amputation at the femur level within 30-d follow-
up. This finding is similar to studies on (ad modum 
Burgess) amputations with long posterior flaps and 
tourniquets[13,14]. 
Patients who require a TTA due to diabetes-related 
complications or severe arteriosclerosis are often old 
and have several co-morbidities[15]. Recent studies 
suggest that a more restrictive strategy towards blood 
transfusions in patients undergoing major amputations 
would be appropriate since blood transfusions appear to 
be associated with post-operative complications, such 
as acute renal failure and pneumonia[16,17]. The use of 
a pneumatic tourniquet around the femur can reduce 
the OBL and, therefore, the transfusion rate and risk 
of transfusion-related complications[13]. However, the 
effect of the tourniquet in TTA surgery is not thoroughly 
described, and the focus has primarily been towards the 
ability to reduce the OBL. 
Our findings of a reduction in the OBL using a tourni-
quet are similar to the findings from a 2006 randomized 
controlled trial[13]. These findings are of no surprise since 
the major vessels are strangulated by the tourniquet and 
under-tied with sutures by the surgeons. It is reasonable 
to assume that the reduction in the OBL will reduce the 
transfusion rate[14]. Our concern was that the tourniquet 
could aggravate the seepage of blood from the wounds 
due to damage to the vessels during the time when the 
tourniquet is inflated. However, we found no statistically 
significant difference between the groups when the TBL 
was calculated on the fourth postoperative day indicating 
no radical change in blood loss. 
The fact that the non-tourniquet group had a greater 
OBL and received more blood transfusions but had a 
similar TBL as the tourniquet group is a dilemma. This 
result could illustrate a late onset drop in Hgb level in 
the patients operated on using tourniquets, pointing 
at increased postoperative bleeding. Thus, it has been 
shown that an exsanguinated human limb will swell 
by approximately 10% of its original volume after the 
release of a pneumatic tourniquet and mainly due 
to the return of the exsanguinated blood volume[6]. 
This delayed reperfusion, which is associated with the 
duration of use of the tourniquet, creates a potential 
source of continuous minor bleeding if the surgeons 
overlook minor vessels not recognized during the time 
when the tourniquet is inflated[18]. Even if the surgical 
field is inspected for minutes after the release of the 
tourniquet, the possible delayed re-perfusion might 
still cause the non-under tied vessels to begin leaking 
when the patients are moved from the operating 
room. However, if serious seepage due to damaged 
vessels was the case, we would have expected a more 
dramatic drop in Hgb and a steeper development in the 
transfusion curve. 
This study has some limitations. Although the 
formula used to calculate the TBL has been used 
widely in other orthopaedic sub-specialties[10,19], it has 
limitations in amputation surgery due to the changes in 
the body surface area after amputation. The patients 
will, because of this, have a different blood volume after 
surgery, which is difficult to correct in the equations. 
However, since we compared two groups with similar 
baseline values and our interests are the change in 
the values between the groups, we believe that the 
calculations are acceptable to illuminate the objectives 
of our study. Potential biases include the operating 
surgeons and the selection of patients for surgery with 
a tourniquet. However, the logistic regression model 
with respect to this matter showed no evidence that a 
specific patient’s characteristics triggers the surgeons to 
use a tourniquet.
In conclusion, the use of a tourniquet reduces the 
duration of surgery, the OBL, and the transfusion rate in 
dysvascular TTA amputations. We found no significant 
Univariable
estimate (95%CI)
P  value Multivariable
estimate (95%CI)
P  value
  Tourniquet (used) -39 (-370-293) 0.810 -78 (-431-275) 0.659
  Age (per year older) -10 (-25-5) 0.210 -7 (-23-9) 0.384
  Women/men (men) 320 (-22-662) 0.066 221 (-149-590) 0.237
  Specialist registrar/consultant (consultant) -335 (-676-6) 0.054 -324 (-689-41) 0.081
  Clopidogrel (in treatment) 33 (-390-456) 0.876 -86 (-520-349) 0.696
  NSAID/acetylsalicylic acid (in treatment) 205 (-124-534) 0.218 223 (-126-572) 0.206
  Duration of surgery (per minute) 1 (-5-7) 0.752 -3 (-10-5) 0.482
  ASA-1-2/ASA 3-4 (ASA 3-4) -1 (424-422) 0.995 -66 (-506-373) 0.764
  Body mass index (per one unit) 21 (-9-52) 0.162 17 (-17-50) 0.322
Table 3  Univariable and multivariate analysis with linear regression of association between risk factors for the total blood loss in the 
74 patients
Variables in parenthesis = reference; NSAID: Nonsteroidal anti-inflammatory drug; ASA: American society of anesthesiologists.
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difference in the TBL when it is calculated on day 
four after surgery or in the 30-d re-amputation rate 
between the tourniquet and the non-tourniquet group. 
From a haemodynamics point of view, it appears to be 
advantageous and safe to use a tourniquet during ad 
modum Persson TTA amputations. 
COMMENTS
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There is an increasing number of high-risk elderly and severely comorbid 
patients scheduled for dysvascular lower extremity amputations. Continuous 
optimization of current procedures is necessary. The use of a tourniquet in 
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the safety aspect regarding the re-amputation rate following (ad modum 
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difference between the groups regarding re-amputation at the femur level within 
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